Browse the evidence

Trans-fatty acids produced through partial hydrogenation increase the risk of ischemic heart disease, whereas saturated and monounsaturated oils are more stable and safer for high-temperature cooking.

When cooking at high heat (frying, searing), use stable fats like butter, ghee, or high-oleic oils. Avoid heating polyunsaturated vegetable oils (like soybean or corn oil) to high temperatures, as they break down into harmful compounds. Trans-fats from partial hydrogenation are harmful and should be avoided.

Adherence to ≥6 unhealthy lifestyle factors (smoking, overweight, physical inactivity, low fruit/veg intake, unbalanced diet) is associated with a 22.67-fold higher risk of stroke compared to 0-1 factors.

Your lifestyle choices compound. Having multiple unhealthy habits (smoking, inactivity, poor diet, overweight) drastically multiplies your stroke risk. To protect yourself, prioritize fixing the most impactful factors first: stop smoking, increase physical activity, and ensure you eat enough fruits and vegetables daily. Even small improvements in these areas significantly lower your risk.

Adequate fruit and vegetable intake (>5 days/week meeting ≥100g/day threshold) and a balanced meat-vegetable diet are protective against stroke, reducing risk by approximately 41-57% compared to low intake or vegan diets.

Eat more fruits and vegetables daily (aim for >100g each) and maintain a balanced diet that includes moderate amounts of meat. This combination is strongly associated with a significantly lower risk of stroke compared to low intake or strict vegan diets. Focus on variety and balance rather than extreme restriction.

Pharmacist-led interventions, including screening, counseling, and medication optimization, significantly improve glycemic control (HbA1c), therapy adherence, and early detection in patients with Type 2 Diabetes.

If you have Type 2 Diabetes, engage your local pharmacist. They can help you understand your medications, improve your adherence to diet and exercise plans, and screen for early signs of complications. This collaborative approach can lead to better blood sugar control and fewer complications.

Adherence to the DASH diet or the Plate Method leads to improved glycemic control, reduced HbA1c, and better blood pressure management in patients with Type 2 Diabetes.

Adopt the DASH diet or the Plate Method. For DASH, focus on fruits, vegetables, whole grains, and low-fat dairy while limiting sodium and saturated fats. For the Plate Method, fill half your plate with non-starchy vegetables, one-quarter with lean protein, and one-quarter with carbohydrates. These approaches have been shown to lower HbA1c and improve blood pressure.

Regular physical activity, specifically 150 minutes per week of moderate-to-vigorous aerobic and resistance exercise, improves insulin sensitivity and glycemic control in Type 2 Diabetes patients.

Aim for 150 minutes of moderate-to-vigorous exercise per week, combining aerobic and resistance activities. If you cannot do it all at once, break it into smaller sessions. Aim for 10,000 steps a day. If you are on insulin, monitor your blood sugar to prevent hypoglycemia.

Outdoor green cycling (3x/week, 30-40 mins) significantly improves psychological well-being (reduced stress, mood disturbance, and depression; increased vigor) and glycemic control (HbA1c) compared to indoor stationary cycling in patients with knee osteoarthritis and type 2 diabetes.

If you have knee pain and diabetes, try cycling outdoors three times a week for 30-40 minutes. This specific type of 'green exercise' not only helps lower your blood sugar better than indoor cycling but also significantly reduces stress and improves your mood, making you more likely to stick with it. Start with supervision to ensure proper form and safety.

Moderate-to-vigorous physical activity (MVPA) performed during morning hours (06:00–12:00) significantly reduces the risk of developing diabetic retinopathy (DR) and slows retinal thinning, whereas late-night physical activity increases DR risk.

If you have diabetes or are at risk, aim for at least 150 minutes of moderate-to-vigorous exercise per week. Crucially, try to schedule these workouts in the morning (between 6 AM and 12 PM). This timing appears to offer the strongest protection against diabetic eye disease. Avoid exercising late at night (midnight to 6 AM), as this may increase your risk.

A self-paced wellness program delivered via a mobile app combined with motivational interviewing significantly improves dietary behavior scores in Head Start educators compared to a control group.

If you are a Head Start educator, try using a self-paced wellness app that offers remote support. The study shows that combining app usage with motivational coaching significantly improves dietary habits over six months, even if you only use the app or only talk to a guide. Start by accessing the app and seeing if you want to speak with a guide; the flexibility is key to making it work for your busy schedule.

Tirzepatide (10 mg and 15 mg) achieves statistically equivalent total body weight loss to sleeve gastrectomy (SG), with both interventions demonstrating superior efficacy compared to other pharmacotherapies.

If you are an adult with obesity, high-dose Tirzepatide (10-15 mg weekly) can help you lose approximately 21% of your body weight, which is statistically the same amount of weight loss achieved by sleeve gastrectomy surgery. This makes it a highly effective non-surgical option, though it requires weekly injections and lifestyle modifications.

Tirzepatide (5, 10, and 15 mg once weekly) produces significantly greater weight loss than both placebo and GLP-1 receptor agonists (semaglutide, dulaglutide) in adults with overweight or obesity.

If you have overweight or obesity, tirzepatide (administered once weekly) is a highly effective pharmacological option for weight loss, outperforming both placebo and existing GLP-1 medications like semaglutide. Expect significant weight reduction (up to ~12.5 kg with the highest dose) and a higher likelihood of achieving major weight loss milestones (5%, 10%, 15%). Be prepared for potential gastrointestinal side effects (nausea, diarrhea), which are common but often manageable and comparable to other drugs in this class. Consult a healthcare provider to determine if you are a candidate based on your BMI and health status.

Maintaining ≥ 7% weight loss at 1 year following a 12-week intensive lifestyle intervention (ILI) in patients with diabetes and obesity predicts sustained cardiometabolic improvements, including lower A1C and better lipid profiles, over 15 years.

For patients with diabetes and obesity, completing a structured lifestyle program and maintaining at least 7% of their body weight loss after one year is a critical milestone. This specific level of sustained weight loss is strongly associated with better long-term blood sugar control (A1C) and lipid profiles over 15 years, even if the initial intensive program ends. Focus on maintaining that initial loss rather than expecting continuous rapid weight loss.

Once-weekly tirzepatide (5, 10, or 15 mg) combined with lifestyle intervention produces statistically significant and clinically meaningful body weight reductions (up to -22.4%) and improvements in cardiometabolic risk factors in Japanese adults with obesity or overweight.

For Japanese adults with obesity or overweight, adding once-weekly tirzepatide to a standard lifestyle program (calorie deficit and exercise) leads to substantial weight loss (up to ~22%) and improves heart health markers like blood pressure and cholesterol. While injections are required, side effects like nausea are common but usually mild and temporary. This treatment is specifically approved and effective for this demographic, who may face higher health risks at lower BMIs compared to other ethnicities.

A remote culinary medicine program integrated with health coaching produces significant, sustained weight loss (approx. 4%) and fat mass reduction in adults with overweight/obesity over 12 months.

To lose weight sustainably, focus on building cooking skills and confidence rather than just counting calories. This program uses weekly 30-minute remote coaching to help you set small, achievable cooking goals and track progress. It works by making home cooking easier and more appealing, leading to an average 4% body weight loss over a year without requiring a professional kitchen.

GPS-enabled physical activity interventions produce significant short-term reductions in body weight and body fat percentage in adults, with effects comparable to or exceeding those of combined physical activity and dietary interventions.

Use a GPS-enabled fitness tracker or app to monitor your daily movement. Focus on consistency rather than perfection. The data shows that short-term, consistent activity tracking (under 3 months) yields the best weight loss results. You do not necessarily need to add a strict diet plan if you are using a smart tracking system, as the behavioral feedback from the device alone can drive significant fat loss. Prioritize ease of use to maintain adherence.

A 12-week low-glycemic index (LGI) diet produces significantly greater reductions in waist circumference, LDL cholesterol, non-HDL cholesterol, and leptin, along with greater increases in GLP-1, compared to a matched low-energy diet (LED) in women with excess body weight, without causing a decline in resting metabolic rate.

To improve your metabolic health and reduce belly fat, switch to a low-glycemic index diet for 12 weeks. Focus on eating foods with a GI of 55 or less freely, limit moderate-GI foods to two servings a day, and avoid high-GI foods. You do not need to strictly count calories; eat until you are satisfied. This approach has been shown to lower bad cholesterol, reduce belly fat more effectively than standard dieting, and improve hormonal markers like GLP-1 without slowing down your metabolism.

Adherence to a Mediterranean diet reduces cardiometabolic risk by improving lipid profiles, lowering blood pressure, and enhancing insulin sensitivity.

Adopt a Mediterranean-style eating pattern by prioritizing plant-based foods, healthy fats like olive oil, and moderate protein from fish and poultry. This approach is linked to lower risks of heart disease and stroke. Focus on long-term adherence rather than strict calorie counting.

The Mediterranean diet reduces visceral adiposity and insulin resistance, key drivers of metabolic syndrome.

Focus on reducing visceral fat by following a Mediterranean diet rich in fiber and healthy fats. This helps improve insulin sensitivity and reduces the risk of metabolic syndrome, even if total body weight changes are gradual.

Discontinuation of semaglutide or tirzepatide therapy within the first year significantly attenuates weight loss and glycemic improvement compared to continuous use, with early discontinuation yielding the poorest outcomes.

If you are using semaglutide or tirzepatide for weight loss, stopping the medication—even for a short time—significantly reduces your chances of losing weight. The data shows that people who stop early lose only 3.6% of their body weight, whereas those who stay on it lose nearly 12%. To achieve clinically meaningful results, you must maintain the prescription and reach a high maintenance dose.

Tirzepatide produces significantly greater weight loss and glycemic improvement than semaglutide when used at comparable maintenance dosages and adherence levels.

If you are choosing between Semaglutide and Tirzepatide, Tirzepatide tends to produce greater weight loss (approx. 12% vs 8% average in this study). However, this benefit is only realized if you stay on the medication. If you struggle with side effects or cost, switching drugs may not solve the problem if you end up discontinuing.

Prevention or delay of type 2 diabetes through intensive lifestyle intervention or metformin is associated with a lower prevalence of microvascular complications (retinopathy, nephropathy, neuropathy) compared to those who progress to diabetes.

Avoiding or delaying the onset of type 2 diabetes significantly reduces your risk of developing serious microvascular complications like eye, kidney, and nerve damage. This benefit is observed even if you don't take medication, as long as you prevent or delay diabetes.

Combination therapy with SGLT2 inhibitors and GLP-1 receptor agonists provides additive and synergistic benefits for Cardiovascular-Kidney-Metabolic (CKM) syndrome by targeting complementary mechanisms, resulting in superior glycemic control, weight loss, and organ protection compared to monotherapy.

If you have Type 2 Diabetes, Heart Failure, Kidney Disease, or Obesity, current medical guidelines strongly support using SGLT2 inhibitors and GLP-1 receptor agonists, either alone or together, to protect your heart and kidneys. These drugs work through different mechanisms to lower blood sugar, reduce weight, and protect organs. While they can be expensive and hard to access, they are considered first-line treatments for high-risk patients. Talk to your doctor about whether combination therapy is appropriate for your specific risk profile, especially if single medications aren't enough.

Low-carbohydrate diets significantly improve glycemic control (HbA1c and FPG) and lipid profiles (reduced triglycerides, increased HDL) in overweight or obese patients with Type 2 Diabetes Mellitus compared to control diets.

If you have Type 2 Diabetes and are overweight, reducing your carbohydrate intake to under 26% of your daily calories can significantly lower your HbA1c and fasting blood sugar. It also improves your blood fat profile by lowering triglycerides and raising good HDL cholesterol, without negatively affecting your LDL. You should work with your doctor to adjust diabetes medications (like insulin) to avoid low blood sugar as you start this diet.

Lifestyle modifications, specifically calorie-restricted diets combined with moderate-intensity aerobic and resistance exercise, are first-line interventions that can induce Type 2 Diabetes remission and improve insulin sensitivity.

Adopt a daily caloric deficit of 500-750 kcal and aim for 150 minutes of moderate exercise (like brisk walking) spread across at least three days, plus resistance training twice a week. This approach is the primary, evidence-based method to manage obesity and potentially reverse Type 2 Diabetes without medication.